DE69433285D1 - Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung - Google Patents

Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung

Info

Publication number
DE69433285D1
DE69433285D1 DE69433285T DE69433285T DE69433285D1 DE 69433285 D1 DE69433285 D1 DE 69433285D1 DE 69433285 T DE69433285 T DE 69433285T DE 69433285 T DE69433285 T DE 69433285T DE 69433285 D1 DE69433285 D1 DE 69433285D1
Authority
DE
Germany
Prior art keywords
hepatitis
connections
determination
methods
virus mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433285T
Other languages
English (en)
Other versions
DE69433285T2 (de
Inventor
William Carman
Richard H Decker
Lesley Wallace
Larry T Mimms
Larry R Solomon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Abbott Laboratories
Original Assignee
University of Glasgow
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow, Abbott Laboratories filed Critical University of Glasgow
Publication of DE69433285D1 publication Critical patent/DE69433285D1/de
Application granted granted Critical
Publication of DE69433285T2 publication Critical patent/DE69433285T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69433285T 1993-05-07 1994-05-09 Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung Expired - Lifetime DE69433285T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59031 1993-05-07
US08/059,031 US5595739A (en) 1993-05-07 1993-05-07 Hepatitis B virus mutants, reagents and methods for detection
PCT/US1994/005090 WO1994026904A1 (en) 1993-05-07 1994-05-09 Hepatitis b virus mutants, reagents and methods for detection

Publications (2)

Publication Number Publication Date
DE69433285D1 true DE69433285D1 (de) 2003-12-04
DE69433285T2 DE69433285T2 (de) 2004-06-24

Family

ID=22020377

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433285T Expired - Lifetime DE69433285T2 (de) 1993-05-07 1994-05-09 Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung

Country Status (8)

Country Link
US (4) US5595739A (de)
EP (1) EP0745128B8 (de)
JP (1) JP3813168B2 (de)
AU (1) AU6908294A (de)
CA (1) CA2162132C (de)
DE (1) DE69433285T2 (de)
ES (1) ES2212796T3 (de)
WO (1) WO1994026904A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
US5750341A (en) * 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
EP0919568A1 (de) * 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Fluchtmutanten des Oberflächenantigens des Hepatitis B Virus
WO2000010991A1 (en) 1998-08-25 2000-03-02 Yale University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
EP1141249A1 (de) * 1998-12-31 2001-10-10 Aventis Pharma S.A. Methode zur trennung von viruspartikeln
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
US6670167B1 (en) * 1999-11-01 2003-12-30 Agouron Pharmaceuticals, Inc. Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
KR100368756B1 (ko) * 2000-02-01 2003-01-24 주식회사 엘지생명과학 비형 간염 표면 항원에 대한 항체 진단 시약의 제조방법,이를 이용하여 수득되는 비형 간염 항원에 대한 항체 진단시약 및 비형 간염 바이러스 항체 진단 시약
ATE469242T1 (de) * 2000-03-27 2010-06-15 Univ Jefferson Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US6583279B1 (en) 2001-01-26 2003-06-24 Becton, Dickinson And Company Sequences and methods for detection of hepatitis B virus
US7202354B2 (en) * 2001-03-30 2007-04-10 Abbott Laboratories Hepatitis B virus surface antigen mutant and methods of detection thereof
AU2002259130A1 (en) * 2001-05-03 2002-11-18 Eli Lilly And Company Agents for treatment of hcv and methods of use
CA2442648C (en) * 2001-05-11 2012-10-16 Pro-Virus, Inc. Oncolytic virus therapy
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
TR200402517T1 (tr) 2002-03-29 2007-12-24 Innogenetics N.V. HBV ilaç direnci tespit metotları
EP2455390A1 (de) 2002-04-12 2012-05-23 Melbourne Health Hepatitis-B-Virusvarianten mit reduzierter Suszeptibilität für Nukleosidanaloga und Verwendungen dafür
US20030219407A1 (en) 2002-05-15 2003-11-27 The Regents Of The University Of California RNA silencing in animals as an antiviral defense
EP1513958B1 (de) 2002-06-14 2011-08-10 Gen-Probe Incorporated Zusammensetzungen zum nachweis von hepatitis-b-virus
JP2004081210A (ja) * 2002-06-28 2004-03-18 Japan Science & Technology Corp システイン残基を改変したタンパク質からなる中空ナノ粒子およびそれを用いた薬剤
AU2006224788B2 (en) 2005-03-15 2012-08-16 Justus-Liebig-Universitat Giessen Variants of Hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
ES2494840T3 (es) 2005-03-15 2014-09-16 Fujirebio Europe N.V. Variantes víricas de la hepatitis B con susceptibilidad reducida a análogos de nucleósidos y usos de las mismas
US8211443B2 (en) * 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
EP1874923A4 (de) * 2005-04-08 2010-08-04 Melbourne Health Varianten des hepatitis-b-virus mit resistenz gegenüber antiviralen nukleosidagentien und anwendungen davon
US20090098531A1 (en) * 2007-09-13 2009-04-16 Abbott Laboratories Detecting hepatitis b virus
US20100136520A1 (en) * 2007-09-13 2010-06-03 Abbott Laboratories Detecting hepatitis b virus
US8138318B2 (en) 2007-09-13 2012-03-20 Abbott Laboratories Hepatitis B pre-S2 nucleic acid
BRPI0918694A2 (pt) * 2008-12-31 2015-12-01 3M Innovative Properties Co processo de detecção de coliforme e kit para uso do mesmo
CN117843811A (zh) 2019-09-30 2024-04-09 吉利德科学公司 Hbv疫苗和治疗hbv的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597606B1 (fr) * 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
US5565354A (en) * 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
IT1241154B (it) * 1990-05-18 1993-12-29 Slavo Metodo e composizione reagente per la determinazione dell'alanina amminotrasferasi e dell'antigene hbsag in uno stesso campione biologico
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid

Also Published As

Publication number Publication date
EP0745128B8 (de) 2004-07-14
US5595739A (en) 1997-01-21
US5591440A (en) 1997-01-07
US5925512A (en) 1999-07-20
CA2162132A1 (en) 1994-11-24
US5593825A (en) 1997-01-14
ES2212796T3 (es) 2004-08-01
EP0745128A4 (de) 2000-01-12
WO1994026904A1 (en) 1994-11-24
DE69433285T2 (de) 2004-06-24
CA2162132C (en) 2001-12-11
EP0745128B1 (de) 2003-10-29
JPH08510129A (ja) 1996-10-29
AU6908294A (en) 1994-12-12
JP3813168B2 (ja) 2006-08-23
EP0745128A1 (de) 1996-12-04

Similar Documents

Publication Publication Date Title
DE69433285D1 (de) Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung
DE69119062D1 (de) Gassack, zusammenbau und dessen verfahren
DE3876886T2 (de) Plasmasammelsatz und verfahren.
DE69331903T2 (de) Veränderte Antikörper, damit zusammenhängende Produkte und Verfahren
DE3782216D1 (de) Fahrzeugtueraufbau und verfahren zu ihrem zusammenbau.
DE69011220T2 (de) Kraftfahrzeug-Überzugsmassen und Verfahren.
DE69006318T2 (de) Glasiertes Metallrohr und Verfahren zu dessen Herstellung.
DE59004578D1 (de) Drucksensor und Verfahren zu seiner Herstellung.
DE69425429D1 (de) Propylenblockcopolymer, verfahren zu dessen herstellung und daraus hergestelltes modifiziertes copolymer
DE3885140T2 (de) Keramischer Verbundwerkstoff und Verfahren zu seiner Herstellung.
DE69114158T2 (de) Immunoglobulin G und Verfahren zu seiner Herstellung.
DE3881669D1 (de) Waermeresistenter verbundkoerper und verfahren zu seiner herstellung.
DE69430006D1 (de) Verbindungen und verfahren
EP0593290A3 (de) Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen.
DE68903399D1 (de) Verfahren zur gasphasenfluorierung.
DE69022016T2 (de) Fluoriniertes copolymer und verfahren zu seiner herstellung.
DE58904666D1 (de) Hartmetallverbundkoerper und verfahren zu seiner herstellung.
DE68914598D1 (de) Keramischer Verbundwerkstoff und Verfahren zu seiner Herstellung.
DE69111927T2 (de) Verfahren zur Entschwefelung von Abgasen.
DE69010036T2 (de) Blockcopolymer und Verfahren zu seiner Herstellung.
DE59104329D1 (de) Plankollektor und verfahren zu seiner herstellung.
DE69016170T2 (de) Specimen-sammelanordnung und verfahren.
DE69002025D1 (de) Vinylidenfluoridcopolymer und verfahren zu seiner herstellung.
DE69004093T2 (de) Klappenventilanordnung und verfahren.
DE69105629D1 (de) Verfahren zur Reinigung von Abgas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition